^
Association details:
Biomarker:No biomarker
Cancer:Burkitt Lymphoma
Regimen:R-CVAD (cyclophosphamide + dexamethasone injection + pegylated liposomal doxorubicin + Rituxan (rituximab) + vincristine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
AIDS-related B-cell lymphomas: treatment…burkitt lymphoma…suggested regimens…other recommended regimen…R-HyperCVAD rituximab, cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with high-dose methotrexate and cytarabine